Hemocath Intelligent Heart Failure Monitoring Platform 

Transforming Treatment for Patients with Heart Failure to Reduce Hospitalisation and Rehospitalization

​DIRECT MONITORING of a Patient’s Heart 

Hemocath medical device is a diagnostic & monitoring pulmonary artery (PA) catheter with multiple microsensors providing the most important measures of cardiac function and fluid status. It communicates with a secure cloud for remote patient monitoring (SaaS, AI, machine learning). ​

​NOTIFYING Clinicians Before a Patient's Next Major Heart Failure

HemoCath platform closely monitors a patient's heart and notifies healthcare professionals when a patient's condition is worsening.

HemoCath provides real-time actionable clinical data guiding cardiologists to make more frequent/accurate medication adjustments for HF patients – so patients more rapidly reach their optimal fluid level – leading to earlier hospital discharge. HemoCath (4F) is easily inserted into a vein on the upper arm and flow-directed to the PA.

​Clinical Studies Showing Reduction in Hospitalisation

Clinical studies have shown a 39% reduction in heart failure hospitalisation with pulmonary artery pressure monitoring. ​( See: PubMed.gov )

Heart failure is a global pandemic affecting at least 26 million people worldwide  —  ​5.7 million people in the US  —  and projections in the near future are worrisome. HF health expenditures are considerable and will increase dramatically with an ageing population.